Within a few years the reduced deuterium content preparation can be an anti-cancer drug
The AHYD Rákkutató és Gyógyszerfejlesztő Kft. (AHYD Cancer Research and Drug Development Ltd.) has taken another significant step towards the registration of the reduced deuterium content water (DDW) as an anticancer medicine.
The total value of the world-wide unique pharmaceutical investment is more than 250 million HUF. The investment was implemented with the help of the Primus Capital Kockázati Tőkealap-kezelő Zrt. (Primus Capital Venture Capital Fund Management Ltd.). The European Union also supported the project with 16.644 million HUF.
Related news
The position of the National Association of Hungarian Dietitians on intermittent fasting
Intermittent fasting (IF) is based on alternating fasting and eating…
Read more >The big protein issue: Hungarians consume too much of it
Overconsumption of animal proteins is characteristic of Hungarians, although according…
Read more >(HU) Az egészségünkön spórolunk a legtöbbször
Sorry, this entry is only available in Hungarian.
Read more >Related news
IKEA is expanding its services in seven large rural towns
In the spirit of affordability and accessibility, IKEA is constantly…
Read more >Summer arrives early with the new flavour of Borsodi Friss
The Borsodi Friss product line is being expanded with a…
Read more >NAK-FruitVeB: there is also plenty of Hungarian horseradish for export
In addition to the domestic market, there is plenty of…
Read more >